The association of posttraumatic stress disorder (PTSD) with cardiovascular disease risk may be mediated by inflammation. Our objective was to examine the association between PTSD and measure s of inflammation and to determine whether these association s are due to shared familial or genetic factors. We measured lifetime history of PTSD using the Structured Clinical Interview for DSM-IV in 238 male middle-aged military veteran twin pairs (476 individuals), selected from the Vietnam Era Twins Registry, who were free of cardiovascular disease at baseline. We assessed inflammation using levels of high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), fibrinogen, white blood cells, vascular cell adhesion molecule-1, and inter cellular adhesion molecule-1 (ICAM-1). Geometric mean levels and percent differences by PTSD were obtained from mixed-model linear regression analyses with adjustment for potential confounders. Within-pair analysis was conducted to adjust for shared family environment and genetics (monozygotic pairs). Overall, 12.4% of participa nts had a lifetime history of PTSD. Adjusted mean levels of hsCRP and ICAM-1 were significantly higher among those with vs. without PTSD [hsCRP: 1.75 vs. 1.31 mg/l (33% difference); ICAM-1: 319 vs. 293 ng/ml (9% difference)]. Adjustment for depression ren dered the association of PTSD with hsCRP non-statistically significant. For IL-6, no consiste nt association was seen. Within-pair analysis produced association s that were similar in direction for all three mar kers but lesser in magnitude for hsCRP and IL-6. There was no evidence of interaction by zygosity. Elevated hsCRP and ICAM-1 are associated with PTSD, and these association s may be confounded by shared non-genetic, anteceden t famil ial and environmental factors.
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Introduction
Posttraumati c stress disorder (PTSD), a disabling anxiety disorder that is secondary to severe psychological stress, is common among military veterans with combat exposure (Friedman et al., 1994) . The lifetime prevalence of PTSD is 15-19% in Vietnam veterans (Dohrenwen d et al., 2006 ) , and it is even higher among those who served in the recent Iraq and Afghanistan conflicts (Hoge et al., 2004) . PTSD is also common in the general population, with a lifetime prevalence of 10-12% in women and 5-6% in men (Kessler et al., 1994; Yehuda, 2002 ) . Increasing evidence points to PTSD as risk factor for the developmen t of atherosclerotic cardiovascu lar disease (Bedi and Arora, 2007; Boscarino , 2008; Player and Peterson, 2011; Kubzansky and Koenen, 2009; Coughlin, 2011 ) . While the proposed mechanis ms for this association between PTSD and cardiovascular disease remain primarily speculative (Boscarino, 2011) , inflammation may play a role; the inflammatory process is central to the developmen t of atheroscl erosis (Libby, 2006; Libby and Theroux, 2005; Rozanski et al., 1999 ) and the stress response may trigger an inflammatory response (Song et al., 1999; Bierhaus et al., 2003 ) . The establishment of an association between PTSD and inflammatory processes might provide a target for intervention and possibly prevent subsequent cardiovascular morbidit y and mortality in those with PTSD.
Thus far, the evidence for an association of PTSD with inflammation is mostly from small studies (n = 15-30) in populations with different PTSD etiologies. For example, PTSD was associated with higher levels of the pro-inflammatory markers C-reactive protein (CRP) and interleuki n 6 (IL-6) in some studies (Spitzer et al., 2010;  
